Orion Market Research
Collagen Vascular Diseases Market Trends, Research Report, Growth, Opportunities, Forecast 2021-2027 Request a sample of our report on Collagen Vascular Diseases https://www.omrglobal.com/request-sample/collagen-vascular-diseases-market
Market:
-----------------------------------------------------------------------------------Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 7803040404
The global collagen vascular diseases market is anticipated to grow at a considerable CAGR of around 7.5% during the forecast period (2021-2027). The key factor to drive the market growth is the increasing prevalence of collagen vascular diseases such as Scleroderma and arthritis. For instance, according to the Journal of Managed Care and Specialty Pharmacy, the prevalence rates of Scleroderma in the US were 15.1 per 100,000 person-years and 25.9 per 100,000 people respectively. Furthermore, according to the Centers for Disease Control and Prevention, in 2040, an estimated 78.4 million US adults aged 18 years and older will have doctor-diagnosed arthritis among them Two-thirds with arthritis will be women. Also, it is estimated that around 34.6 million adults in the US will report arthritis-attributable activity limitations as well in 2040. A full report of Collagen Vascular Diseases Market is https://www.omrglobal.com/industry-reports/collagen-vascular-diseases-market
available
at:
Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in December 2019, Pfizer Inc announced that the US Food and Drug Administration (FDA) has approved XELJANZ XR for once-daily treatment of patients with moderate to severely active rheumatoid arthritis those who have an inadequate response to methotrexate. With this approval, Pfizer Inc will be able to offer patients and their healthcare providers with moderate to severely active ulcerative colitis a convenient one daily dosing treatment option with Xeljianz. To learn more about this report request a free sample copy @ https://www.omrglobal.com/requestsample/collagen-vascular-diseases-market Market Coverage
The market number available for – 2020-2027 Base year- 2020 Forecast period- 2021-2027 Segment Coveredo By Disease Type o By Diagnostics o By Therapeutics o By End-User Regions Coveredo North America o Europe o Asia-Pacific o Rest of the World Competitive AbbVie Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Pfizer Inc, Beckman Coulter, Inc., and Bayer AG, among others.
Key questions addressed by the report
What is the market growth rate? Which segment and region dominate the market in the base year? Which segment and region will project the fastest growth in the market? How COVID-19 impacted the market? o Deviation from the pre-COVID-19 forecast o Most affected region and segment Who is the leader in the market? How players are addressing challenges to sustain growth? Where is the investment opportunity?
For more customized data, request for report customization @ https://www.omrglobal.com/reportcustomization/collagen-vascular-diseases-market Global Collagen Vascular Diseases Market Report Segment By Disease Type
Autoimmune Collagen Vascular Diseases o Lupus o Rheumatoid Arthritis o Scleroderma Hereditary Collagen Vascular Diseases
By Diagnostics
Complete Blood Count Erythrocyte Sedimentation Rate (ESR) C-Reactive Protein Rheumatoid Factor Others (Urinalysis with Microscopic Analysis & Serum Creatinine)
By Therapeutics
Corticosteroids Immunosuppressive Agents Endothelin Receptor Antagonists Others (Calcium Channel Blockers, PDE-5 Inhibitors & Chelating Agents)
By End-Users
Hospital & Clinics Diagnostic Centers Research Institutes
Global Collagen Vascular Diseases Market Report Segment by Region North America
United States Canada
Europe
Germany United Kingdom France Spain Italy Rest of Europe
Asia-Pacific
China Japan India Rest of Asia-Pacific
Rest of the World
Middle East & Africa Latin America
Company Profiles
AbbVie Inc. Amgen Inc. Bayer AG` Bio-Rad Laboratories, Inc. Bristol-Myers Squibb Co. Cadila Pharmaceuticals Ltd
Corbus Pharmaceuticals Holdings, Inc. Cytori Therapeutics Inc. Danaher Corp. Eli Lilly and Co. F. Hoffmann-La Roche Ltd. GenWay Biotech Inc. ImmuPharma PLC Pfizer Inc. Sanofi SA Siemens Healthcare AG Thermo Fisher Scientific, Inc. Svar Life Science AB MorphoSys AG Merck & Co., Inc.
Reasons to Buying From us – 1. 2. 3. 4.
We cover more than 15 major industries, further segmented into more than 90 sectors. More than 120 countries are for analysis. Over 100+ paid data sources mined for investigation. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other researchbased services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 7803-040-404